Clinical

August 17, 2018
Shawn Davis, PharmD, highlights the potential for treating primary axillary hyperhidrosis with glycopyrronium tosylate, an emerging treatment option.
August 17, 2018
Dee Anna Glaser, MD; Adelaide Hebert, MD; and Andy Szczotka, PharmD, discuss an emerging therapy, glycopyrronium tosylate, highlighting its anticipated indication, towelette formulation, and clinical study data showing its safety, efficacy, and benefit to patients.
August 17, 2018
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
August 16, 2018
A recent study found that the poly (ADP-ribose) polymerase (PARP) inhibitor talazoparib extended progression-free survival (PFS) and improved quality of life over chemotherapies for patients with metastatic human epidermal growth factor 2 (HER2)-negative breast cancer and mutations in the BRCA 1/2 genes.
August 16, 2018
A new technology platform utilizing artificial intelligence (AI) could change how drug combinations are designed and help doctors to identify optimal personalized drug combinations for patients with multiple myeloma.
August 16, 2018
Sagar Lonial, MD, FACP, considers the constantly improving outcomes of patients with multiple myeloma given the advent of newer and more efficacious combination strategies.
August 16, 2018
Brittany Estrin discusses what she wants people without hyperhidrosis to understand about the disease and how the advice she gives her son, who also has hyperhidrosis, addresses the unmet needs of the disease.
August 16, 2018
Brittany Estrin offers her advice for other patients her age with hyperhidrosis and her advice for doctors on treating the disease based on the experiences she has had.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!